Logo image of DALN

DALLASNEWS CORP (DALN) Stock Fundamental Analysis

NASDAQ:DALN - Nasdaq - US2350501019 - Common Stock - Currency: USD

6.2  -0.39 (-5.92%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DALN. DALN was compared to 93 industry peers in the Media industry. DALN has a bad profitability rating. Also its financial health evaluation is rather negative. DALN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DALN had negative earnings in the past year.
In the past year DALN has reported a negative cash flow from operations.
DALN had negative earnings in 4 of the past 5 years.
In the past 5 years DALN reported 4 times negative operating cash flow.
DALN Yearly Net Income VS EBIT VS OCF VS FCFDALN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.82%, DALN is doing worse than 78.16% of the companies in the same industry.
Industry RankSector Rank
ROA -9.82%
ROE N/A
ROIC N/A
ROA(3y)-8.49%
ROA(5y)-4.89%
ROE(3y)-106.88%
ROE(5y)-63.88%
ROIC(3y)N/A
ROIC(5y)N/A
DALN Yearly ROA, ROE, ROICDALN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

DALN's Gross Margin of 95.50% is amongst the best of the industry. DALN outperforms 98.85% of its industry peers.
DALN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DALN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y1.01%
DALN Yearly Profit, Operating, Gross MarginsDALN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

2

2. Health

2.1 Basic Checks

DALN does not have a ROIC to compare to the WACC, probably because it is not profitable.
DALN has less shares outstanding than it did 1 year ago.
DALN has less shares outstanding than it did 5 years ago.
DALN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DALN Yearly Shares OutstandingDALN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
DALN Yearly Total Debt VS Total AssetsDALN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -7.99, we must say that DALN is in the distress zone and has some risk of bankruptcy.
DALN has a Altman-Z score of -7.99. This is amonst the worse of the industry: DALN underperforms 93.10% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.99
ROIC/WACCN/A
WACC9.06%
DALN Yearly LT Debt VS Equity VS FCFDALN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.09 indicates that DALN should not have too much problems paying its short term obligations.
The Current ratio of DALN (1.09) is worse than 70.11% of its industry peers.
DALN has a Quick Ratio of 1.04. This is a normal value and indicates that DALN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.04, DALN is not doing good in the industry: 70.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.04
DALN Yearly Current Assets VS Current LiabilitesDALN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

DALN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.76%, which is quite good.
Looking at the last year, DALN shows a very negative growth in Revenue. The Revenue has decreased by -11.40% in the last year.
The Revenue has been decreasing by -7.14% on average over the past years.
EPS 1Y (TTM)13.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182.18%
Revenue 1Y (TTM)-11.4%
Revenue growth 3Y-3.26%
Revenue growth 5Y-7.14%
Sales Q2Q%-9.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DALN Yearly Revenue VS EstimatesDALN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
DALN Yearly EPS VS EstimatesDALN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DALN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DALN Price Earnings VS Forward Price EarningsDALN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DALN Per share dataDALN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.70%, DALN is a good candidate for dividend investing.
DALN's Dividend Yield is rather good when compared to the industry average which is at 4.48. DALN pays more dividend than 100.00% of the companies in the same industry.
DALN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 10.7%

5.2 History

The dividend of DALN decreases each year by -8.16%.
DALN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-8.16%
Div Incr Years0
Div Non Decr Years0
DALN Yearly Dividends per shareDALN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

DALN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-28.31%
EPS Next 2YN/A
EPS Next 3YN/A
DALN Yearly Income VS Free CF VS DividendDALN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

DALLASNEWS CORP

NASDAQ:DALN (2/21/2025, 8:11:49 PM)

6.2

-0.39 (-5.92%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)03-10 2025-03-10
Inst Owners42.24%
Inst Owner Change-25.41%
Ins Owners5.77%
Ins Owner Change4.69%
Market Cap33.17M
Analysts82.86
Price TargetN/A
Short Float %4.49%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 10.7%
Yearly Dividend0.64
Dividend Growth(5Y)-8.16%
DP-28.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS23.98
BVpS-0.11
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.5%
FCFM N/A
ROA(3y)-8.49%
ROA(5y)-4.89%
ROE(3y)-106.88%
ROE(5y)-63.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y1.01%
F-Score4
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 350.19%
Cap/Sales 4.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.04
Altman-Z -7.99
F-Score4
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)51.53%
Cap/Depr(5y)38.47%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.4%
Revenue growth 3Y-3.26%
Revenue growth 5Y-7.14%
Sales Q2Q%-9.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.18%
OCF growth 3YN/A
OCF growth 5YN/A